drugset / Trial / NCT00574886

Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy

NCT00574886

NaSingle-groupOpen-labelTreatment

Summary

This is a compassionate use protocol for participants who failed induction chemotherapy + Vaccine on previous trials. These participants then went on to high dose BEAM chemotherapy and transplant, then received idiotype vaccine therapy at 3 months post transplant. Vaccine was given monthly x 4 series, with a fifth series given 12 weeks after the fourth. Participants were then followed annually until progression or death with standard staging.

Timeline

Start
2000-08-03
Primary completion
2002-03-01
Completion
2008-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Id-KLH Vaccine 0.5 mg Subcutaneous

Indications